Effects of indomethacin on polymorphonuclear leukocyte and monocyte phagocytosis and oxidative burst in vitro

International Journal of Immunopathology and Pharmacology

Volumn 11, Issue 1, 1998, Pages 29-34

  Lukac J ^a,b   Vrsalovic M ^a   Kovacevic D ^b   Kapitanovic S ^c   Kusic Z ^a  

^a Department of Oncology ^*  (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Indomethacin; Monocytes; Oxidative burst; Phagocytosis; Polymorphonuclear leukocytes

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL KILLING; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NATURAL KILLER CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RESPIRATORY BURST;

EID: 0031718929     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brooks P.M. and R.O. Day. 1991. Nonsteroidal antiinflaminatory drugs - Differences and similarities. New Engl. J. Med. 324:1716.
2. Uotila P. 1993. Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy. Cancer Immunol. Immunother. 7:251.
3. Goodwyn J.S. 1985. Immunological effects of nonsteroidal anti-inflammatory agents. Med. Clin. North Am. 69:793.
4. Muscoplat C.C., P.M. Rakich and C.O. Thoen. 1978. Enhancement of lymphocyte blastogenic and delayed hypersensitivitiy skin responses by indomethacin. Infect. Immun. 20:627.
5. Baxevanis C., G.J. Reclos, A.D. Gritzapis, G.V.Z. Dedousus, I. Missitzis and M. Papamichail. 1993. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 72:491.
6. Sacerdote P. and A.E. Panerai. 1993. Effect of tenoxicam and indomethacin on the chemotaxis induced by substance P and interleukin-8 on human monocytes and polymorphonuclear cells. Int. J. Tiss. React. 15:175.
7. Lukač J., Z. Kusić, D. Kordić, M. Konèar and A. Bolanèa. 1994. Natural killer cell activity, phagocytosis and number of peripheral blood cells in breast cancer patients treated with tamoxifen. Breast Cancer Res. Treat. 29:279.
8. Cathcart R., E. Schwiers and B.N. Ames. 1983. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Analyt. Biochem. 134:111.
9. Gerber C.E, S. Kuci, M. Zipfel, D. Niethammer and G. Bruchelt. 1996. Phagocytic activity and oxidative burst of granulocytes in persons with myeloperoxidase deficiency. Eur. J. Clin. Chem. Clin. Biochem. 34:901.
10. Pang L. and J.R.S. Hoult. 1996. Induction of cyclooxygenase and nitric oxide synthase in endotoxin activated J774 macrophages is differentially regulated by indomethacin: Enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase. Eur. J. Pharmacol. 317:151.
11. Gustafson-Svard C., I. Lilja, O. Hallbook and R. Sjodahl. 1996. Cyclooxygenase-1 andcyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumors in rats. Gut 38:79.
12. Lora M., S. Morisset., H.A. Menard, R. Leduc and A.J. de Brum-Fernandes. 1997. Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin. Prostaglandins Leuko. Essent. Fatty Acids 56:361.
13. Di Virgilio F., O. Stendahl, D. Pittet, P.D. Lew and T. Pozzan. 1990. Cytoplasmic calcium in phagocyte activation. Curr. Top. Membr. Transp. 35:180
14. Weiss H.A. and D. Forman. 1996. Aspirin, nonsteroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence. Scand. J. Gastroenterol. 31 (Suppl 220): 137.
15. Berkel H.J., R.F. Holcombe, M. Middlebrooks and K. Kannan. 1996. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol. Rev. 18:205.
16. Pelus L. and H. Strausser. 1977. Prostaglandins and the immune response. Life. Sci. 20:903.
17. Young M. and M. Dizer. 1983. Enhancement of immune functions and tumor growth inhibition by antibodies against prostaglandin E2. Immunol. Commun. 12:11.
18. Gustafson-Svard C., I. Lilja, O. Hallbook and R. Sjodahl. 1997. Cyclo-oxygenase and colon cancer: Clues to the aspirin effect? Ann. Med. 29:247.
19. Munn D.H. and V.N.K. Cheung. 1990. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J. Exp. Med. 172:231.
20. Korner S. 1992. Tumor cells elicit the respiratory burst in cytotoxic, activated bone marrow-derived macrophages (BMDM). Pathobiology 60 (S1):18.
21. Chaudhauri S.W., A. Sinha, A. Sengupta and S. Chaudhauri. 1991. Sheep erythrocytes provide metabolic triggers for tumor phagocytosis in polymorphonuclear neutrophils: A possible mechanism of tumor inhibition in mice. Biochem. International 23:231.
22. Murano E.A. and C.S. Cummins. 1989. Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine. Cancer. Immunol. Immunother. 29:7.